A Prospective Multicenter Study Of The Bruton'S Tyrosine Kinase Inhibitor Ibrutinib In Patients With Relapsed Or Refractory Waldenstrom'S Macroglobulinemia

BLOOD(2013)

引用 35|浏览22
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要